Ou L, Setegne M, Elliot J, Shen F, Dassama L
Chem Rev. 2025; 125(4):2120-2183.
PMID: 39818743
PMC: 11870016.
DOI: 10.1021/acs.chemrev.4c00595.
Hampton J, Liu W
Chem Rev. 2024; 124(9):6051-6077.
PMID: 38686960
PMC: 11082904.
DOI: 10.1021/acs.chemrev.4c00004.
Palma M
Vaccines (Basel). 2023; 11(2).
PMID: 36851313
PMC: 9967953.
DOI: 10.3390/vaccines11020436.
Andre A, Moutinho I, Dias J, Aires-da-Silva F
Front Microbiol. 2022; 13:962124.
PMID: 36225354
PMC: 9549074.
DOI: 10.3389/fmicb.2022.962124.
Liu B, Yang D
Int J Mol Sci. 2022; 23(3).
PMID: 35163405
PMC: 8835997.
DOI: 10.3390/ijms23031482.
Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).
Lu J, Ding J, Liu Z, Chen T
Int J Oncol. 2022; 60(2).
PMID: 34981814
PMC: 8759346.
DOI: 10.3892/ijo.2022.5302.
Perspectives on passive antibody therapy and peptide-based vaccines against emerging pathogens like SARS-CoV-2.
Palma M
Germs. 2021; 11(2):287-305.
PMID: 34422699
PMC: 8373402.
DOI: 10.18683/germs.2021.1264.
Sortase-Mediated Phage Decoration for Analytical Applications.
Ding Y, Chen H, Li J, Huang L, Song G, Li Z
Anal Chem. 2021; 93(34):11800-11808.
PMID: 34415158
PMC: 8853704.
DOI: 10.1021/acs.analchem.1c02322.
The development of inovirus-associated vector vaccines using phage-display technologies.
Stern Z, Stylianou D, Kostrikis L
Expert Rev Vaccines. 2019; 18(9):913-920.
PMID: 31373843
PMC: 7103683.
DOI: 10.1080/14760584.2019.1651649.
Identification of an Immunogenic Broadly Inhibitory Surface Epitope of the Plasmodium vivax Duffy Binding Protein Ligand Domain.
George M, Schloegel J, Ntumngia F, Barnes S, King C, Casey J
mSphere. 2019; 4(3).
PMID: 31092602
PMC: 6520440.
DOI: 10.1128/mSphere.00194-19.
Cognizance of Molecular Methods for the Generation of Mutagenic Phage Display Antibody Libraries for Affinity Maturation.
Lim C, Choong Y, Lim T
Int J Mol Sci. 2019; 20(8).
PMID: 30991723
PMC: 6515083.
DOI: 10.3390/ijms20081861.
Landscape Phage: Evolution from Phage Display to Nanobiotechnology.
Petrenko V
Viruses. 2018; 10(6).
PMID: 29880747
PMC: 6024655.
DOI: 10.3390/v10060311.
Phage display as a promising approach for vaccine development.
Aghebati-Maleki L, Bakhshinejad B, Baradaran B, Motallebnezhad M, Aghebati-Maleki A, Nickho H
J Biomed Sci. 2016; 23(1):66.
PMID: 27680328
PMC: 5041315.
DOI: 10.1186/s12929-016-0285-9.
Toxoplasma gondii-Derived Synthetic Peptides Containing B- and T-Cell Epitopes from GRA2 Protein Are Able to Enhance Mice Survival in a Model of Experimental Toxoplasmosis.
Bastos L, Macedo Jr A, Silva M, Santiago F, Ramos E, Santos F
Front Cell Infect Microbiol. 2016; 6:59.
PMID: 27313992
PMC: 4888622.
DOI: 10.3389/fcimb.2016.00059.
Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.
Karimi M, Mirshekari H, Moosavi Basri S, Bahrami S, Moghoofei M, Hamblin M
Adv Drug Deliv Rev. 2016; 106(Pt A):45-62.
PMID: 26994592
PMC: 5026880.
DOI: 10.1016/j.addr.2016.03.003.
Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.
Henry K, Arbabi-Ghahroudi M, Scott J
Front Microbiol. 2015; 6:755.
PMID: 26300850
PMC: 4523942.
DOI: 10.3389/fmicb.2015.00755.
Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines.
Hassapis K, Stylianou D, Kostrikis L
Viruses. 2014; 6(12):5047-76.
PMID: 25525909
PMC: 4276942.
DOI: 10.3390/v6125047.
Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.
Costa L, Goulart L, de Jesus Pereira N, Lima M, Duarte M, Martins V
PLoS One. 2014; 9(10):e110014.
PMID: 25333662
PMC: 4198211.
DOI: 10.1371/journal.pone.0110014.
Phage display creates innovative applications to combat hepatitis B virus.
Tan W, Ho K
World J Gastroenterol. 2014; 20(33):11650-70.
PMID: 25206271
PMC: 4155357.
DOI: 10.3748/wjg.v20.i33.11650.
Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.
Costa L, Lima M, Chavez-Fumagalli M, Menezes-Souza D, Martins V, Duarte M
Clin Vaccine Immunol. 2013; 21(1):96-106.
PMID: 24256622
PMC: 3910914.
DOI: 10.1128/CVI.00583-13.